- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Marksans Pharma Limited — Updates, 15-10-2025: Press Release
15-10-2025 | 02:06 pm
15-10-2025 | 02:06 pm
Marksans Pharma's UK subsidiary, Relonchem, secured market authorization for two Clonidine tablets in the UK. This allows commercialization, potentially boosting future revenue streams.
No comments yet. Be the first to comment!